ArticleFrontiers in psychiatry2025
Cognitive symptoms in schizophrenia: an analysis of awareness, assessment, and management practices among psychiatrists and primary care physicians.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Understanding the burden of cognitive impairment associated with schizophrenia: Results from the international LUCIA study.European psychiatry : the journal of the Association of European Psychiatrists · 2026Article
- Does neurocognition predict personal recovery over time in psychotic disorder patients?Schizophrenia research. Cognition · 2026Article
- Associations of TNF-α, MIF, and cortisol with cognitive function in patients with bipolar disorder during acute manic episodes: a short-term follow-up study.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cognitive symptoms contribute to the worsening of functionality in people with schizophrenia. The objective of this study was to explore the current knowledge about cognitive symptoms (relevance, evaluation, and management) of psychiatrists and primary care physicians (PCPs) involved in the care of patients with schizophrenia in Spain. Methods: The study was developed in two phases: a quantitative phase and a qualitative one. Both took place between November 2023 and January 2024. For the quantitative phase, an online questionnaire was developed and administered to 100 psychiatrists and 125 PCPs. In addition, further qualitative data were collected through individual semi-structured telephone interviews. Descriptive analyses and qualitative analyses (induction-deduction approach) were carried out. Results: Health professionals agreed that cognitive symptoms are present in patients with schizophrenia, with 75% of psychiatrists and 45% of PCPs acknowledging this. Both groups also considered the detection of these symptoms as crucial for improving patient functionality (89% psychiatrists vs 88% PCPs). However, over half of both psychiatrists and PCPs do not consistently evaluate cognitive symptoms, attributing this to factors such as time constraints, limited access to both pharmacological and non-pharmacological treatments, and a lack of effective diagnostic tools. PCPs additionally highlighted insufficient training regarding cognitive symptoms in schizophrenia. Both groups underscored the need for specific treatments for cognitive symptoms, with 87% agreement. Conclusion: This study offers an overview of the current understanding regarding the relevance, evaluation, and management of various cognitive symptoms according to clinical practice in Spain. The results highlight the necessity for enhanced guidelines, training, and improved access to effective treatments to address cognitive symptoms in patients with schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.